Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Small nuclear RNA-activating protein complex subunit 1 (SNAPC1)** is a core component of the snRNA-activating protein complex (SNAPc), which is essential for transcription initiation of small nuclear RNA (snRNA) genes by both RNA polymerase II and III[2][3][7]. SNAPC1 binds to the proximal sequence element (PSE) in snRNA promoters, a specialized DNA motif upstream of the transcription start site, and helps recruit the basal transcription machinery, including TBP (TATA-binding protein, even at TATA-less promoters) and other SNAPc subunits[1][2][5]. The protein is predominantly localized in the nucleolus and nucleoplasm[3] and forms the SNAPc core together with SNAPC3 and SNAPC4; these subunits are highly conserved across species[1][5]. Loss of SNAPC1 function disrupts snRNA transcription and is incompatible with cell viability[5], but there is currently no verified link to specific human diseases nor any known pharmacological modulators[3][7][5]. Key structural and functional features: - SNAPC1 contains an amino-terminal VHS/ENTH-like domain important for SNAPc complex stability and DNA binding[1]. - The SNAPc complex binds snRNA gene promoters at the PSE, acts upstream of TBP, and can mediate DNA opening and transcription initiation without canonical general transcription factors TFIIE and TFIIH[1]. - SNAPC1 interacts with SNAPC3, SNAPC4, and possibly BRF2 and Retinoblastoma protein (pRb)[2][6]. There is no evidence that SNAPC1 is a direct therapeutic target, enzyme, transporter, receptor, or ion channel. The protein is a fundamental and highly conserved component of basal transcriptional machinery in eukaryotic cells[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear RNA-activating protein complex subunit 1 (SNAPC1).